# A Global Active Surveillance for Community Acquired Pneumonia

> **NCT00929721** · NA · COMPLETED · sponsor: **Pfizer** · enrollment: 5172 (actual)

## Conditions studied

- Community Acquired Pneumonia

## Interventions

- **PROCEDURE:** Blood draw
- **PROCEDURE:** Chest X-ray
- **PROCEDURE:** urine specimen
- **PROCEDURE:** Nasopharyngeal swab
- **PROCEDURE:** sputum

## Key facts

- **NCT ID:** NCT00929721
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-01
- **Final completion:** 2012-02
- **Target enrollment:** 5172 (ACTUAL)
- **Last updated:** 2012-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00929721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00929721, "A Global Active Surveillance for Community Acquired Pneumonia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00929721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
